Opthea-spon Adr logo

Opthea-spon Adr Share Price (NASDAQ: OPT)

▲

-3.41

(-100%)

Last updated on

Check the interactive Opthea-spon Adr Stock chart to analyse performance

Opthea Ltd-spon Adr Key Stats

Check Opthea-spon Adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.41
Open
$3.48
Market Capitalization
$524.8M
Today's Volume
$3.0K
Revenue TTM
$208.9K
EBITDA
$-183.2M
Earnings Per Share (EPS)
$-2.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3383.08%

Stock Returns calculator for Opthea-spon Adr Stock including INR - Dollar returns

The Opthea-spon Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Opthea-spon Adr investment value today

Current value as on today

₹5,284

Returns

₹94,716

(-94.72%)

Returns from Opthea-spon Adr Stock

₹1,00,000 (-100%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Opthea-spon Adr Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Opthea-spon Adr Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Opthea Ltd-spon Adr

  • Name

    Holdings %

  • VGI PARTNERS PTY Ltd

    3.37%

  • Baker Bros Advisors LP

    1.36%

  • HSBC Holdings PLC

    0.07%

  • Millennium Management LLC

    0.03%

  • Twin Lakes Capital Management, LLC

    0.02%

  • OLD MISSION CAPITAL LLC.

    0.01%

Analyst Recommendation on Opthea-spon Adr Stock

Rating
Trend

Sell

    11%Buy

    33%Hold

    55%Sell

Based on 9 Wall street analysts offering stock ratings for Opthea-spon Adr(by analysts ranked 0 to 5 stars)

Opthea-spon Adr Share Price Target

What analysts predicted

Upside of 9.223372036854776E16%

Target:

$1.33

Opthea Ltd-spon Adr Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$82.8K
↓ 22.65%
Net Income
$-146.3M
↑ 3.95%
Net Profit Margin
-176.7K%
↓ 45195.93%

Opthea-spon Adr Technicals Summary

Sell

Neutral

Buy

Opthea-spon Adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

About Opthea Ltd-spon Adr

Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia.
Organization
Opthea-spon Adr
Employees
33
CEO
Dr. Frederic Guerard M.S., Pharm.D.
Industry
Health Technology

Key Management of Opthea Ltd-spon Adr

NameTitle
Dr. Frederic Guerard M.S., Pharm.D.
Chief Executive Officer
Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.
Founder & Chief Innovation Officer
Ms. Karen Adams CPA
VP of Finance & Company Secretary
Mr. Thomas Charles Reilly
Chief Financial Officer
Mr. Kevin Bitter
VP of Strategy & Corporate Development
Mr. Anand Sundaram
Vice President Marketing
Dr. Fang Li Ph.D.
Senior Vice President of Regulatory Affairs
Dr. Julie Clark M.D., M.S.
Senior Vice President of Clinical Development
Dr. Arshad M. Khanani M.A., M.D.
Chief Medical Advisor & Chairman of Medical Advisory Board
Ms. Jen Watts
VP Global Clinical Operations

Important FAQs about investing in OPT Stock from India :

What is Opthea-spon Adr share price today?

Opthea-spon Adr share price today is as on at the close of the market. Opthea-spon Adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Opthea-spon Adr share?

Opthea-spon Adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Opthea-spon Adr stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Opthea-spon Adr Stock (OPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Opthea-spon Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Opthea-spon Adr Shares .

What is the minimum amount required to buy Opthea-spon Adr Stock (OPT) from India?

Indian investors can start investing in Opthea-spon Adr (OPT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Opthea-spon Adr stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Learn more about fractional shares .

What are the returns that Opthea-spon Adr has given to Indian investors in the last 5 years?

Opthea-spon Adr stock has given -72.28% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?